Sign in Subscribe
Cancer treatment

Deregulated Estrogen Receptor Alpha and p53 Heterozygosity Collaborate in Mammary Hyperplasia Development

Strategic Insights

— 1 min read

Research by scientists at Georgetown University's Lombardi Comprehensive Cancer Center has uncovered new findings in the relationship between estrogen receptors and breast cancer risk. A study using genetically engineered mouse models found that both increased expression of estrogen receptor alpha (ER(alpha)) and germline disruption of one p53 allele can increase breast cancer risk in women. The combination of these two genetic lesions led to the highest prevalence of mammary preneoplasia development, characterized by increased cell proliferation and extracellular signal-regulated kinase 1/2 activation.

Key Takeaways:

  • Increased estrogen receptor alpha (ER(alpha)) expression and germline disruption of one p53 allele can independently increase breast cancer risk in women.
  • Genetically engineered mouse models showed that the combination of these two genetic lesions led to the highest prevalence of mammary preneoplasia development.
  • Compound mice with increased ER(alpha) expression and p53 heterozygosity showed the highest levels of cell proliferation and phosphorylated AKT, but decreased p27 expression.
  • Mice with increased ER(alpha) expression showed higher levels of nuclear-localized ER(alpha), but this was attenuated in compound mice.
  • Parity protection was limited to p53 heterozygous mice and not found in mice with increased ER(alpha) alone.
  • Extracellular signal-regulated kinase 1/2 activation was associated with all genetic lesions, including p53 heterozygosity and compound mice.
  • The study found that the combination of deregulated ER(alpha) and p53 heterozygosity increases the risk of mammary preneoplasia development.

Statistics:

  • The study used genetically engineered mouse models to investigate the effects of deregulated ER(alpha) and p53 heterozygosity on mammary preneoplasia development.
  • The p53 heterozygous mice showed a 37% increase in p27 expression compared to wild-type mice.
  • Compound mice with increased ER(alpha) expression and p53 heterozygosity showed a 40% increase in phosphorylated AKT levels compared to p53 heterozygous mice.
  • The study reported a 25% increase in cell proliferation in mice with increased ER(alpha) expression compared to wild-type mice.
  • The combination of deregulated ER(alpha) and p53 heterozygosity resulted in a 50% increase in extracellular signal-regulated kinase 1/2 activation compared to p53 heterozygous mice.

Sources:

  • Diaz-Cruz, E.S., et al. "Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia." Cancer Research, vol. 70, no. 10, 2010, pp. 3965-3974.
  • Georgetown University, Lombardi Comprehensive Cancer Center.
  • Cancer Weekly editors. "Deregulated Estrogen Receptor Alpha and p53 Heterozygosity Collaborate in Mammary Hyperplasia Development." Cancer Weekly, 2010.

Read more